603367.SS Stock Analysis
60
Neutral
Based on Eyestock quantitative analysis, 603367.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Cisen Pharmaceutical Ltd. engages in the manufacturing of comprehensive chemical and pharmaceutical products. The company is headquartered in Jining, Shandong and currently employs 3,206 full-time employees. The company went IPO on 2017-09-29. The firm operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.